Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine versus granisetron for prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy
IRCT20200910048678N1Phase 3Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lidocaine and granisetron in postoperative nausea and vomiting (PONV) (3 arms), sponsored by Zanjan University of Medical Sciences. Primary endpoint: Postoperative nausea and vomiting. Started Sep 2020; status: completed.
02
Drugs
lidocainegranisetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20200910048678N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200910048678N1.